Peptides, explained: what they are and what the evidence supports

A chemical description, not a drug class

A peptide is simply a short chain of amino acids, the same building blocks that make up proteins. That description tells you about structure, not about safety, effectiveness or legal status. Hormones like insulin and oxytocin are peptides, and so are some of the newest weight-loss medicines.

Peptides are also not steroids. Steroid hormones are built from cholesterol, while most peptides act by binding to receptors on the surface of cells. Because they are broken down in the gut, many peptides have to be injected, though some are made in oral or under-the-tongue forms.

Three very different categories under one word

When someone says they are taking a peptide, they could mean any of three things, and the differences are large.

• FDA-approved peptide drugs: products like semaglutide, tirzepatide and bremelanotide that went through clinical trials and FDA review for a specific use
• Compounded peptides: preparations made by a licensed pharmacy for an individual prescription; these are not FDA-approved and have not had FDA review for safety, effectiveness or quality
• Research-use-only products: substances sold online labeled 'for research purposes' or 'not for human consumption'; FDA warns their quality is unknown and they may be harmful

Where the regulatory picture stands

Pharmacies that compound under section 503A can use a bulk drug substance only if it meets certain conditions, and FDA has used interim categories to sort nominated substances. Category 2 is for substances with identified significant safety risks. In 2023 several popular peptides, including BPC-157, TB-500, epitalon, MOTS-c, KPV and DSIP, were placed there.

In 2026 that changed. In April, the nominations for 12 peptides were withdrawn and they were removed from Category 2, and FDA's page now lists them as withdrawn nominations. In July 2026, FDA's Pharmacy Compounding Advisory Committee voted to recommend adding BPC-157, TB-500, MOTS-c, KPV and epitalon to the 503A bulks list, and voted against DSIP.

Those votes are advisory. As of this writing, FDA still has to complete rulemaking before any of these substances is formally added to the list, and state pharmacy boards can set their own limits. Status can change quickly, so any provider should be able to tell you where a specific peptide stands today.

How strong the evidence is

Evidence for peptides spans a wide range. Approved drugs like semaglutide and tirzepatide have large randomized trials. Sermorelin, a growth hormone-releasing hormone analog, was once FDA-approved and has a longer human record, though its approved product was discontinued. Bremelanotide is approved as Vyleesi for a specific group of premenopausal women.

Many of the most heavily promoted compounded peptides sit at the other end. BPC-157 and TB-500 are supported mainly by animal and cell studies. Epitalon's telomere claims come largely from laboratory and animal work. MOTS-c is interesting metabolically but has very limited human data. Promising early research is a reason for more study, not proof that a product works or is safe in people.

Names you will see, and what is known about them

• Semaglutide and tirzepatide: FDA-approved for weight management and type 2 diabetes in branded forms, with large randomized trials; compounded versions are not FDA-approved
• Bremelanotide (PT-141): FDA-approved as Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women; other uses are off-label
• Sermorelin: a growth hormone-releasing hormone analog that raises the body's own growth hormone; human data are older and limited for anti-aging uses
• BPC-157 and TB-500: promoted for tissue repair, with evidence mostly from animal and laboratory studies
• Epitalon: promoted for telomeres and aging, with evidence largely from laboratory and animal research
• MOTS-c: a mitochondria-derived peptide studied for metabolism, with very limited human data
• DSIP: promoted for sleep; older studies are small and inconsistent, and the 2026 advisory committee voted against adding it to the bulks list

Side effects and when to call

Even when a peptide is well tolerated, side effects can happen. Injection-site redness, swelling or pain are common with any injected product. Nausea, flushing, headache and changes in blood pressure have been reported with some peptides; bremelanotide, for example, commonly causes nausea and can temporarily raise blood pressure.

Stop and contact your clinician if you notice signs of infection at an injection site, hives or swelling of the face or throat, chest pain, a severe headache or anything that worries you. Adverse events can also be reported to FDA's MedWatch program.

Natural does not mean safe

Because many peptides resemble molecules the body makes, they are often marketed as natural. That says little about what happens when you inject a concentrated amount for months. Contamination, incorrect potency, injection-site reactions and unknown long-term effects are real concerns, especially with products bought outside a licensed pharmacy.

What a legitimate prescription looks like

A responsible peptide prescription starts with a licensed clinician who takes a history, reviews medications and, when relevant, orders baseline labs. Fatigue, poor sleep, slow recovery and low libido often have causes that show up on a panel and have better-proven treatments.

If a peptide is still a reasonable option, it should be dispensed by a named, state-licensed pharmacy, with a clear explanation of the regulatory status, the quality of the evidence and the goal you are trying to reach. You should leave with a plan for when to reassess and when to stop.

How to judge a provider

• Is a licensed clinician actually reviewing your case, not just an intake form?
• Do they measure before prescribing when your symptoms call for it?
• Will they name the pharmacy that fills the prescription?
• Do they describe compounded products as not FDA-approved?
• Are the evidence claims specific and honest about animal-only data?
• Is there a defined goal, review date and exit plan?
• Do they avoid research-use-only products and dosing advice for home mixing?

Before you start: practical points

Tell your clinician about every medication and supplement you take, and about any history of cancer, since some peptides influence growth pathways. If you compete in tested sport, check anti-doping rules first, because many peptides are prohibited. Pregnancy and breastfeeding are reasons not to use these products.

Peptides at HealifyMD

HealifyMD clinicians may prescribe certain compounded peptides when they judge it appropriate and when state and federal rules allow, filled by licensed U.S. pharmacies. These products are not FDA-approved, and your clinician will explain the limits of the evidence. For example, BPC-157 is listed from $250 per month; prices are confirmed during your eligibility review and labs are priced separately.